Category: St. Jude Medical
A federal judge sends a $570 million lawsuit filed against Boston Scientific by the family of Dr. Michel Mirowski, credited with inventing the implantable cardioverter defibrillator, back to a Maryland state court.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
St. Jude Medical says it's complete its $455 million acquisition of CardioMEMS and its Champion HF implantable heart monitor, just days after FDA approval of the device.
St. Jude Medical (NYSE:STJ) wasted no time in closing its acquisition of CardioMEMS, days after the FDA approved the Champion HF implantable heart monitor, saying it plans to begin a "strategic" launch of the device in the U.S.
A look at some of the top medical device companies suggests that the long-lamented medical device tax hasn't had much of an impact on their research & development budgets.
MASSDEVICE ON CALL — Despite repeated warnings and laments, the medical device tax implemented with healthcare reform hasn't appeared to make much of a dent in the industry's research & development activities, according to a small report.
St. Jude Medical says that its next-gen EnligHTN renal denervation system appears safe and effective in treating hypertension, but docs at this year's EuroPCR conference are calling for more robust clinical trials.
Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott may look to expand medical device business footprint; Device makers take big writedowns on renal denervation; Cardinal Health closes $320M AccessClosure buy; K2M prices IPO under range at $132M; Allergan board spurns Valeant's $47B offer.
Access Closure Inc.
, Boston Scientific
, Cardinal Health
, Pershing Capital Management
, St. Jude Medical
, Valeant Pharmaceuticals
, Abbott Laboratories
, Allergan Inc.
St. Jude Medical launches a U.S. study of its Portico transcatheter aortic valve in patients who are not candidates for open heart surgery.
Minnesota medtech maker St. Jude Medical (NYSE:STJ) launched a U.S. study of its Portico catheter-based aortic valve, enrolling the 1st patients in pursuit of FDA approval for the implant.